Loading...
Market
Story
Eli Lilly to Invest $1.8 Billion to Expand Drug Manufacturing in Ireland Facility
Sep 12, 2024, 09:32 AM
Eli Lilly, valued at $863.36 billion as of September 10, is making a significant investment to expand its manufacturing capabilities. The pharmaceutical giant announced a $1.8 billion investment to boost production of its blockbuster drugs for weight loss, diabetes, and Alzheimer's disease. This expansion includes a €927 million investment at its facility in Raheen, Limerick, Ireland, which will create 150 new jobs. The move underscores Lilly's commitment to addressing the growing demand for treatments in these critical areas.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Increase by more than 50% • 25%
Increase by 30-50% • 25%
Increase by 10-30% • 25%
Increase by less than 10% • 25%
Yes • 50%
No • 50%
Less than $25 billion • 25%
$25 billion to $30 billion • 25%
$30 billion to $35 billion • 25%
More than $35 billion • 25%